Amgen Inc. (AMGN) News Headlines

▮ More

Date

Headline

1/29/2019 4:04:22 PM Amgen Inc. Q4 adjusted earnings Beat Estimates

1/29/2019 4:02:02 PM Amgen Q4 GAAP EPS Increase To $3.01

1/29/2019 3:01:03 PM Amgen Q4 18 Earnings Conference Call At 5:00 PM ET

1/29/2019 6:06:03 AM Amgen Q4 18 Earnings Conference Call At 5:00 PM ET

1/24/2019 4:01:25 PM Amgen Secures NMPA Approval For Repatha In China To Reduce The Risk Of Cardiovascular Events

1/24/2019 9:19:26 AM Amgen : ABP 798 Study Meets Primary Endpoint Of Pharmacokinetic Similarity

1/24/2019 9:03:26 AM Amgen And Allergan Announce Results From Phase 1/ Phase 3 Study Of ABP 798, Biosimilar Candidate To Rituximab

1/22/2019 9:04:13 AM Amgen Says EC Approved An Expanded Indication For BLINCYTO (blinatumomab) Monotherapy

1/17/2019 1:00:29 AM FDA Panel Nod For Osteoporosis Drug, PTIE Gets Research Funding, ALDR On Watch

1/16/2019 5:42:50 PM Amgen, UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For EVENITY

1/9/2019 2:22:53 AM Japan Approves Amgen/UCB's Osteoporosis Drug - Will U.S. Follow Suit?

1/2/2019 8:32:51 PM Teva, Amgen Settle Dispute Over Teva's Generic Cinacalet HCl Product

1/2/2019 8:29:33 PM Teva And Amgen Resolve Dispute Over Teva’s Generic Cinacalet HCl Product

12/24/2018 5:13:44 AM Biotech Stocks Facing FDA Decision In January 2019

12/18/2018 11:08:15 PM Amgen And Molecular Partners Collaborate In Immuno-Oncology

12/18/2018 11:01:52 PM Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology

12/17/2018 9:30:27 AM Amgen Submits BLA For ABP 710 To FDA - Quick Facts

12/17/2018 9:03:00 AM Amgen Submits BLA To FDA For ABP 710, A Biosimilar Candidate To REMICADE

12/7/2018 4:21:12 PM Amgen Inc. (AMGN) Declares Quarterly Dividend of $ 1.45, Record Date 2/15/2019

12/7/2018 4:03:40 PM Amgen Declares Q1 Dividend Of $1.45, Payable March 8/ Record Feb. 15